| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH |
|
|
|
||||||||
|
||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dr. Ward is Managing Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Halpern is Strategic Director, Health Services Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Schrag is Epidemiologist, Health Services Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Cokkinides is Strategic Director, Cancer Risk Factors and Screening, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. DeSantis is Epidemiologist, Cancer Surveillance, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Bandi is Epidemiologist, Cancer Risk Factors and Screening, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Siegel is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Stewart is Senior Manager, National Cancer Data Base, Commission on Cancer, American College of Surgeons, Chicago, IL.
Dr. Jemal is Strategic Director, Cancer Surveillance, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
ABSTRACT
Advances in the prevention, early detection, and treatment of cancer have resulted in an almost 14% decrease in the death rates from all cancers combined from 1991 to 2004 in the overall US population, with remarkable declines in mortality for the top 3 causes of cancer death in men (lung, colorectal, and prostate cancer) and 2 of the top 3 cancers in women (breast and colorectal cancer). However, not all segments of the population have benefited equally from this progress, and evidence suggests that some of these differences are related to lack of access to health care. Lack of adequate health insurance appears to be a critical barrier to receipt of appropriate health care services. This article provides an overview of systems of health insurance in the United States, demographic and socioeconomic characteristics associated with health insurance coverage, and economic burdens related to health care among individuals and families. This article also presents data on the association between health insurance status and screening, stage at diagnosis, and survival for breast and colorectal cancer based on analyses of the National Health Interview Survey and the National Cancer Data Base. Although this article focuses on associations between health insurance and cancer care utilization and outcomes, it is important to recognize that barriers to receipt of optimal cancer care are complex and involve patient-level, provider, and health system factors. Evidence presented in this paper suggests that addressing insurance and cost-related barriers to care is a critical component of efforts to ensure that all Americans are able to share in the progress that can be achieved by access to high-quality cancer prevention, early detection, and treatment services.
This article has been cited by other articles:
|
|
 |
|
  I. K. Komenaka, M. E. Martinez, R. E. Pennington Jr, C.-H. Hsu, S. E. Clare, P. A. Thompson, C. Murphy, N. M. Zork, and R. J. Goulet Jr Race and Ethnicity and Breast Cancer Outcomes in an Underinsured Population J Natl Cancer Inst, August 4, 2010; 102(15): 1178 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. W. Hofstatter Understanding Patient Perspectives on Communication About the Cost of Cancer Care: A Review of the Literature J. Oncol. Pract, July 1, 2010; 6(4): 188 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Davidoff, M. Tang, B. Seal, and M. J. Edelman Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non-Small-Cell Lung Cancer J. Clin. Oncol., May 1, 2010; 28(13): 2191 - 2197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. T. Levy, J. M. Daly, B. Luxon, M. L. Merchant, Y. Xu, C. E. Levitz, and J. K. Wilbur The "Iowa Get Screened" Colon Cancer Screening Program Journal of Primary Care & Community Health, April 1, 2010; 1(1): 43 - 49. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Lobb, J. D. Allen, K. M. Emmons, and J. Z. Ayanian Timely Care After an Abnormal Mammogram Among Low-Income Women in a Public Breast Cancer Screening Program Arch Intern Med, March 22, 2010; 170(6): 521 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gupta, L. Tong, J. E. Allison, E. Carter, M. Koch, D. C. Rockey, P. Anderson, C. Ahn, K. Argenbright, and C. S. Skinner Screening for Colorectal Cancer in a Safety-Net Health Care System: Access to Care Is Critical and Has Implications for Screening Policy Cancer Epidemiol. Biomarkers Prev., September 1, 2009; 18(9): 2373 - 2379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Meropol, D. Schrag, T. J. Smith, T. M. Mulvey, R. M. Langdon Jr, D. Blum, P. A. Ubel, and L. E. Schnipper American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care J. Clin. Oncol., August 10, 2009; 27(23): 3868 - 3874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Robbins, A. L. Pavluck, S. A. Fedewa, A. Y. Chen, and E. M. Ward Insurance Status, Comorbidity Level, and Survival Among Colorectal Cancer Patients Age 18 to 64 Years in the National Cancer Data Base From 2003 to 2005 J. Clin. Oncol., August 1, 2009; 27(22): 3627 - 3633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. D. Chu, M. H. Smith, M. Williams, L. Panu, L. W. Johnson, R. Shi, B. D.L. Li, and J. Glass Race/Ethnicity Has No Effect on Outcome for Breast Cancer Patients Treated at an Academic Center with a Public Hospital Cancer Epidemiol. Biomarkers Prev., August 1, 2009; 18(8): 2157 - 2161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Chang, S. J. Shema, H. A. Wakelee, C. A. Clarke, and S. L. Gomez Uncovering Disparities in Survival after Non-Small-Cell Lung Cancer among Asian/Pacific Islander Ethnic Populations in California Cancer Epidemiol. Biomarkers Prev., August 1, 2009; 18(8): 2248 - 2255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. W. Brawley, D. P. Ankerst, and I. M. Thompson Screening for Prostate Cancer CA Cancer J Clin, July 1, 2009; 59(4): 264 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H.M. Keegan, L. A. McClure, J. M. Foran, and C. A. Clarke Improvements in Survival After Follicular Lymphoma by Race/Ethnicity and Socioeconomic Status: A Population-Based Study J. Clin. Oncol., June 20, 2009; 27(18): 3044 - 3051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Hassett and J. J. Griggs Disparities in Breast Cancer Adjuvant Chemotherapy: Moving Beyond Yes or No J. Clin. Oncol., May 1, 2009; 27(13): 2120 - 2121. [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Palmieri, E. R. Deperi, B. A. Mincey, J. A. Smith, L. K. Wen, D. M. Chewar, R. Abaya, G. Colon-Otero, and E. A. Perez Comprehensive Diagnostic Program for Medically Underserved Women With Abnormal Breast Screening Evaluations in an Urban Population Mayo Clin. Proc., April 1, 2009; 84(4): 317 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Smith, V. Cokkinides, and O. W. Brawley Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening CA Cancer J Clin, January 1, 2009; 59(1): 27 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Virnig, N. N. Baxter, E. B. Habermann, R. D. Feldman, and C. J. Bradley A Matter Of Race: Early-Versus Late-Stage Cancer Diagnosis Health Aff., January 1, 2009; 28(1): 160 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Pentheroudakis, R. Stahel, H. Hansen, and N. Pavlidis Heterogeneity in cancer guidelines: should we eradicate or tolerate? Ann. Onc., December 1, 2008; 19(12): 2067 - 2078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Warren, A. B. Mariotto, A. Meekins, M. Topor, and M. L. Brown Current and Future Utilization of Services From Medical Oncologists J. Clin. Oncol., July 1, 2008; 26(19): 3242 - 3247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. T. Shih and M. T. Halpern Economic Evaluations of Medical Care Interventions for Cancer Patients: How, Why, and What Does it Mean? CA Cancer J Clin, July 1, 2008; 58(4): 231 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Nolte and C. M. McKee Amenable Mortality: The Authors Respond Health Aff., July 1, 2008; 27(4): 1197 - 1197. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Smith, V. Cokkinides, and O. W. Brawley Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues CA Cancer J Clin, May 1, 2008; 58(3): 161 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Huerta Editorial CA Cancer J Clin, January 1, 2008; 58(1): 7 - 8. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH |
